Venture Life Buys Back 152,056 Shares, Updates Voting Rights

Venture Life ( (GB:VLG) ) has provided an update.

Venture Life Group has continued to execute its share buyback programme, repurchasing 152,056 ordinary shares at a volume-weighted average price of 68.55 pence, with the shares to be held in treasury. Following this transaction, the company has 128,860,145 ordinary shares in issue, of which 6,534,824 are held in treasury, leaving 122,325,321 voting rights outstanding, a figure shareholders can use to assess disclosure thresholds under FCA rules.

The most recent analyst rating on (GB:VLG) stock is a Hold with a £67.00 price target. To see the full list of analyst forecasts on Venture Life stock, see the GB:VLG Stock Forecast page.

Spark’s Take on VLG Stock

According to Spark, TipRanks’ AI Analyst, VLG is a Neutral.

Venture Life’s stock score is primarily supported by strong technical indicators and positive corporate events, such as share buybacks and insider buying, which suggest confidence in future prospects. However, the high P/E ratio and profitability challenges weigh down the score, indicating potential overvaluation and financial risks.

To see Spark’s full report on VLG stock, click here.

More about Venture Life

Venture Life Group is an international consumer self-care company operating in the global consumer healthcare sector, focused on proactive healthy longevity, product innovation, development and commercialisation. Headquartered in the UK, it markets brands such as Balance Activ, Earol, Lift, Glucogel and Health & Her, distributing primarily through pharmacies, health and beauty retailers, grocery multiples and e-commerce, both directly in key markets and via international partners elsewhere.

Average Trading Volume: 300,679

Technical Sentiment Signal: Buy

Current Market Cap: £83.28M

For an in-depth examination of VLG stock, go to TipRanks’ Overview page.